Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sean P. Nolan currently holds 2,908,257 shares of Taysha Gene Therapies, Inc. (TSHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean P. Nolan has been a net seller of TSHA stock. They have purchased $426.1K and sold $5.6M worth of shares.
Sean P. Nolan's most recent insider trade was on Jan 26, 2026, when they sold 41,312 shares at $4.61 per share.
Sean P. Nolan serves as Executive at Taysha Gene Therapies, Inc. (TSHA). They have executed 44 insider transactions totaling $6.0M over their tenure at the company.
Sean P. Nolan holds the position of Executive at Taysha Gene Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Sean P. Nolan has shown a selling trading pattern, with $426.1K in total purchases and $5.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sean P. Nolan was on Sep 29, 2014, when they sold $4.2M worth of ITMN shares. This transaction involved 56,400 shares at $74.00 per share.
Sean P. Nolan currently owns 2,908,257 shares of Taysha Gene Therapies, Inc. (TSHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sean P. Nolan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sean P. Nolan has 44 Form 4 filings on record as an insider at Taysha Gene Therapies, Inc..
Set alerts for Sean P. Nolan and 40,000+ other insiders.